The phrase "achieved the endpoint" is correct and usable in written English.
It can be used in contexts where a goal or target has been reached, particularly in technical, project management, or personal achievement discussions.
Example: "After months of hard work, we finally achieved the endpoint of our project, and the results exceeded our expectations."
Alternatives: "reached the goal" or "attained the target."
Radiofrequency application duration was defined as the cumulative length of all RF applications necessary to achieve the endpoint.
To achieve the endpoint 50% f T>MIC, sample A is taken mid-way through the dosing interval to see if the drug concentration exceeds the MIC.
By monitoring the drying kinetics (data not shown) no significant differences in the drying rates (steady and falling drying rate) and the drying time required to achieve the endpoint water activity (0.45 0.48) were detected.
Non-inferiority to allopurinol was to be declared for febuxostat 40 mg if the value of the lower limit of the 95% CI for the difference in achieving the endpoint was greater than -10%.
For each of the four treatment response criteria, the estimated probability of achieving the endpoint at or before week 16 of atomoxetine treatment was at least 50%, and by week 20 it was at least 60%.
Such an individual generally has fewer financial resources to begin with and thus requires additional individual skills in order to achieve the endpoint of adequate financial planning over a lifespan.
All six patients achieved the target endpoint of a pain score of less than three out of ten sustained for at least 8 h.
Only two Edmonton protocol treated patients achieved the primary endpoint; six required islets from multiple donors, and all experienced leukopenia, mouth ulcers, anemia, diarrhea and hypertransaminasemia. Four became allosensitized.
In the STRIVE placebo-controlled Phase 3 trial in patients with episodic migraine (EM; clinicaltrials.gov NCT02456740), erenumab 70 mg and 140 mg administered monthly by subcutaneous injection achieved the primary endpoint of significantly reducing the number of monthly migraine days versus placebo.
Erenumab also achieved the secondary endpoint of reducing the number of days/month versus placebo on which patients used acute migraine-specific medications (AMSM, triptans or ergotamines; −0.9 and −1.4 days/month averaged over Months 4−6 for erenumab 70 mg and 140 mg, respectively [p<0.001 for each dose]).
